Nachrichten zur Pfizer Inc. Aktie

Opko Health (OPK) Q2 Revenue Falls 14%

Key PointsRevenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and…

Eli Lilly, Pfizer und Johnson & Johnson im Visier der US-Regierung und auch Novo Nordisk hat momentan wenig zu lachen

Das Geschäftsmodell der großen Pharmakonzerne ist nicht nur weitgehend krisensicher, sondern auch enorm lukrativ. Zu verdanken ist dies zu nicht…

Trump Demands Pharma Companies to Lower US Prices

US President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies demanding they charge the US what…

Pfizer (PFE) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Pfizer (PFE) closed at $23.27, indicating a -2.29% shift from the previous trading day.…

Trump will Pharmakonzerne zu günstigeren Preisen zwingen

Bei seinen Bemühungen um deutlich niedrigere Medikamentenpreise nimmt US-Präsident Donald Trump große Pharmakonzerne in die Pflicht. Binnen 60 Tagen sollten…

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.…

AKTIEN IM FOKUS: Pharma unter Druck - Trump will günstigere Preisen

NEW YORK (dpa-AFX) - Die Aussicht auf politischen Druck auf die Medikamentenpreise in den USA hat am Donnerstag die Branche…

Trump will Pharmakonzerne zu günstigeren Preisen zwingen

WASHINGTON (dpa-AFX) - Bei seinen Bemühungen um deutlich niedrigere Medikamentenpreise nimmt US-Präsident Donald Trump große Pharmakonzerne in die Pflicht. Binnen…

Where Will Pfizer (PFE) Be in 5 Years? @themotleyfool #stocks $PFE $BNTX

The big drugmaker should be even bigger over the next five years despite facing a patent cliff.…

Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?

Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Pfizers Comeback Is Underway

…

GNW-News: Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an LP.8.1 angepassten COVID-19-Impfstoff in der Europäischen Union

^* Daten zeigten, dass der an LP.8.1 angepasste COVID-19-Impfstoff verglichen mit den COVID-19-Impfstoffformulierungen 2024-2025 eine verbesserte …

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

NEW YORK and MAINZ, GERMANY, July 25, 2025 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”)…

Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

Key PointsPfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it…

AIM weekly movers: Oxford BioDynamics gains recognition from Pfizer trial

Oil and gas producer Empyrean Energy (LON: EME) says the operator of the Mako field has signed a gas sales…

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

The companies new effort would bypass traditional middlemen to cut the drugs monthly cost from a list price of around…

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients

US drugmakers Bristol Myers and Pfizer said on Thursday that they will make their blood thinner, Eliquis, available directly to…

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients By Reuters

Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients…

This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

Key PointsPfizer’s earnings and stock price soared in early pandemic days thanks to its coronavirus treatment and vaccine.But waning demand…

AIM movers: Pfizer confirms efficacy of Oxford BioDynamics EpiSwitch and Sosandar write down reduces profit

Oxford BioDynamics (LON: OBD) says Pfizer has published information on its use of EpiSwitch biomarkers as a liquid biopsy in…

How Will Pfizers Oncology Drugs Perform in Q2 Earnings?

PFEs oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.…

Pfizer (PFE) Stock Sinks As Market Gains: Heres Why

Pfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior days close.…

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

A Message to All Investors From Motley Fool CEO Tom Gardner

Motley Fool co-founder and CEO Tom Gardner gets candid on stock market fears, what new investors should avoid, stock market…

JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?

JNJs growth outlook, rising estimates, and strength in Innovative Medicine give it an edge over Pfizer in 2025.…

Pfizer (PFE) Ascends While Market Falls: Some Facts to Note

Pfizer (PFE) closed at $25.62 in the latest trading session, marking a +1.51% move from the prior day.…

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Key PointsThese stocks have all fallen between 19% and 87% over the past decade.Changing market conditions and consumer tastes and…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

Warren Buffett Owns 9 Ultra-High-Yield Dividend Stocks. Heres the Best of the Bunch.

Key PointsBuffetts Berkshire Hathaway portfolio includes only one ultra-high-yield stock.However, his "secret portfolio" is loaded with ultra-high-yielders.The best of the…

The Best Dividend Stocks Id Buy Right Now

Key PointsEven Warren Buffett appreciates the power of dividend stocks. These companies sport meaningful payouts and promising prospects.See which ones…

2 Stocks to Buy With Less Than $50

Key PointsPfizer is slowly building a foundation that will help its business recover from recent headwinds.Encouraging developments on the clinical…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

Pfizer: Options Activity Speaks Bullish

…

Is Pfizer Stock a Yield Trap? @themotleyfool #stocks $PFE $NVS $BMY $BBIO

…

Pfizer (PFE) Outperforms Broader Market: What You Need to Know

In the latest trading session, Pfizer (PFE) closed at $25.32, marking a +1.12% move from the previous day.…

Pfizers Strong Late-Stage Pipeline Can Drive Long-Term Growth

PFEs robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.…

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could…

Former Pfizer executive probed on alleged Covid vaccine delay

Former Pfizer executive probed on alleged Covid vaccine delay - CNN…

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports By Reuters

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports…

3 No-Brainer Stocks to Buy for Under $100 Right Now

Whats the biggest misconception about investing? The idea that you need a lot of money to get started is certainly…

Want to Collect $2,000 in Dividends Each Year? Heres How Much You Should Aim to Invest in the Stock Market Today.

You can generate a lot of recurring cash flow from the stock market without having to worry about selling your…

PFEs Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal

Pfizers Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with inhibitors.…

Pfizer announces positive results for hemophilia treatment By Investing.com

Pfizer announces positive results for hemophilia treatment…

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

…

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Pfizer (PFE) stood at $24.31, denoting a +1.17% move from the preceding…

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of…

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest…

10 Stocks That Pay $100 or More in Dividends

Looking for stocks that pay $100 in annual income? Youve come to the right place. Even a small investment in…

Beyond Air (XAIR) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATETuesday, June 17, 2025, at 4:30 p.m. EDTCALL PARTICIPANTSChairman and Chief Executive Officer — Steven Adam…